Dr. Gillespie is a native of Chicago, IL, received his undergraduate and Ph.D. degrees from the University of Kentucky in 1977 and 1981, respectively. He was a postdoctoral Fellow at the University of Colorado’s Cardiovascular-Pulmonary Research Laboratory until 1982 after which he was recruited back to the University of Kentucky where he rose to the rank of Professor and Chairperson of Pharmacology and Experimental Therapeutics. In 1995, he relocated to his current affiliation, the University of South Alabama, where he serves as Professor and Chair of Pharmacology and founding member of the Center for Lung Biology. Over the past two decades, Dr. Gillespie has served as ad hoc or regular member or chairperson of multiple NIH study sections and held leadership positions in organizations dedicated to lung health and disease. His research program, supported continuously by the NIH and other agencies for the past 30 years, focuses on selected aspects of lung biology and pathology, most recently concentrating on how oxidative damage and repair in the nuclear and mitochondrial genomes dynamically regulates lung cell responses to oxidant stress.